Collplant Biotechnologies LTCLGN

13F holders, Q2 2026 (June 30)
15holders −5
1new positions
6sold out
2famous investors
$0.35avg. 13F price*

At the end of Q2 2026, 15 institutions reported holding Collplant Biotechnologies LT (CLGN) in their 13F filings, down 5 from Q1 2026. 1 opened new positions and 6 sold out. The largest holders were Pinnacle Associates Ltd. ($255K), Villere St Denis J & Co. LLC ($212K) and Brown Advisory Inc. ($37K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Collplant Biotechnologies LT
CUSIP
M2R51X116
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 12Q1 2024Q2 2024: 15Q2 2024Q3 2024: 12Q3 2024Q4 2024: 13Q4 2024Q1 2025: 15Q1 2025Q2 2025: 17Q2 2025Q3 2025: 18Q3 2025Q4 2025: 16Q4 2025Q1 2026: 20Q1 2026Q2 2026: 15Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions1$59
Exits6$48K

All 13F filers, Q1 2026 → Q2 2026: 248,778 shares bought and 106,439 shares sold, net +142,339 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

Pinnacle Associates Ltd. 0.00% Add +33.0% 731,663 $255K
Villere St Denis J & Co. LLC 0.03% Reduce -0.1% 606,400 $212K
Brown Advisory Inc. 0.00% Reduce -11.8% 104,731 $37K
Renaissance Technologies 0.00% Add +266.1% 61,500 $21K
Pathstone Holdings, LLC 0.00% No change 57,000 $20K
Citadel Advisors 0.00% Add +67.0% 53,700 $19K
Legacy Wealth Managment, LLC 0.00% No change 23,179 $8K
Waters Parkerson & Co., LLC 0.00% No change 13,250 $5K
XTX Topco Ltd 0.00% Reduce -11.6% 13,081 $5K
FNY Investment Advisers, LLC 0.00% Reduce -0.9% 5,250 $1K
UBS Group AG 0.00% Add +989.5% 1,035 $361
Osaic Holdings, Inc. 0.00% No change 345 $120
SBI Securities Co., Ltd. 0.00% No change 200 $70
Strive Financial Group ,LLC 0.00% New 169 $59
Morgan Stanley 0.00% No change 1 $1

"% of holder's portfolio" is CLGN's weight in each manager's 13F, not the share of Collplant Biotechnologies LT the manager owns.